IDYA
Price
$21.82
Change
+$0.24 (+1.11%)
Updated
Jul 21, 04:13 PM (EDT)
Capitalization
1.89B
22 days until earnings call
IMTX
Price
$5.82
Change
-$0.18 (-3.00%)
Updated
Jul 21, 04:14 PM (EDT)
Capitalization
729.3M
22 days until earnings call
Interact to see
Advertisement

IDYA vs IMTX

Header iconIDYA vs IMTX Comparison
Open Charts IDYA vs IMTXBanner chart's image
IDEAYA Biosciences
Price$21.82
Change+$0.24 (+1.11%)
Volume$200
Capitalization1.89B
Immatics
Price$5.82
Change-$0.18 (-3.00%)
Volume$600
Capitalization729.3M
IDYA vs IMTX Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. IMTX commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (IDYA: $21.59 vs. IMTX: $6.00)
Brand notoriety: IDYA and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 50% vs. IMTX: 28%
Market capitalization -- IDYA: $1.89B vs. IMTX: $729.3M
IDYA [@Biotechnology] is valued at $1.89B. IMTX’s [@Biotechnology] market capitalization is $729.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMTX is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 2 TA indicator(s) are bullish while IMTX’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 2 bullish, 6 bearish.
  • IMTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -3.96% price change this week, while IMTX (@Biotechnology) price change was +0.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.62%. For the same industry, the average monthly price growth was +16.07%, and the average quarterly price growth was +35.46%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

IMTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.89B) has a higher market cap than IMTX($729M). IMTX (-15.612) and IDYA (-15.992) have similar YTD gains . IMTX has higher annual earnings (EBITDA): -4.49M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. IMTX (544M). IMTX has less debt than IDYA: IMTX (18.4M) vs IDYA (26M). IMTX has higher revenues than IDYA: IMTX (144M) vs IDYA (7M).
IDYAIMTXIDYA / IMTX
Capitalization1.89B729M259%
EBITDA-356.46M-4.49M7,941%
Gain YTD-15.992-15.612102%
P/E RatioN/A29.35-
Revenue7M144M5%
Total Cash693M544M127%
Total Debt26M18.4M141%
FUNDAMENTALS RATINGS
IDYA vs IMTX: Fundamental Ratings
IDYA
IMTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
9490
PRICE GROWTH RATING
1..100
5950
P/E GROWTH RATING
1..100
10058
SEASONALITY SCORE
1..100
n/a32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (61) in the null industry is in the same range as IMTX (62). This means that IDYA’s stock grew similarly to IMTX’s over the last 12 months.

IDYA's Profit vs Risk Rating (80) in the null industry is in the same range as IMTX (100). This means that IDYA’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (90) in the null industry is in the same range as IDYA (94). This means that IMTX’s stock grew similarly to IDYA’s over the last 12 months.

IMTX's Price Growth Rating (50) in the null industry is in the same range as IDYA (59). This means that IMTX’s stock grew similarly to IDYA’s over the last 12 months.

IMTX's P/E Growth Rating (58) in the null industry is somewhat better than the same rating for IDYA (100). This means that IMTX’s stock grew somewhat faster than IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAIMTX
RSI
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 5 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 22 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALPBX12.570.01
+0.08%
ALPS/Smith Balanced Opportunity I
PRJQX47.85-0.09
-0.19%
PGIM Jennison Global Opportunities R6
RPEAX40.39-0.19
-0.47%
Davis Opportunity A
FESCX10.41-0.07
-0.67%
First Eagle Small Cap Opportunity I
LCMNX8.90-0.07
-0.78%
Miller Income C

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with CGON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.26%
CGON - IDYA
61%
Loosely correlated
N/A
IMNM - IDYA
61%
Loosely correlated
+1.24%
DNLI - IDYA
60%
Loosely correlated
-3.65%
NRIX - IDYA
59%
Loosely correlated
-7.28%
XENE - IDYA
59%
Loosely correlated
N/A
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-3.38%
RGNX - IMTX
50%
Loosely correlated
-6.10%
OCUL - IMTX
49%
Loosely correlated
-0.44%
IDYA - IMTX
49%
Loosely correlated
-2.26%
CRNX - IMTX
48%
Loosely correlated
-5.78%
CGON - IMTX
48%
Loosely correlated
N/A
More